News

The company gains right to 18 prescription drugs through this acquisition, which includes ImmuCyst, an immunotherapy for superficial bladder cancer; gelclair, an oral gel for the management of

EHSI said that the term sheet review is a positive step that is necessary to pursue final terms under EHSI’s recent option agreement with ThromboVision, a company that

The conversion allows Predictor to be used with customer-specific electrocardiogram acquisition equipment to generate the signal-averaged ECG. The software can be easily customised to interface with a variety

The hospital said that HIT investment is part of a transformational initiative to better serve Englewood Hospital’s patient community while enabling the hospital to qualify for incentives under

Denzapine is indicated in treatment resistant schizophrenic patients and in schizophrenia patients who have severe, untreatable neurological adverse reactions to other antipsychotic agents, including atypical antipsychotics. The company

The FDA had a thorough inspection of the Naroda facility and cleared after it was found to be suitable for manufacturing export-purpose APIs. The facility is an Export

The company has initiated its phase IIb clinical trial for CVac in the US, under the auspices of the FDA, and intends to start recruitment of patients shortly.

As per the agreement, BioMarin will pay LEAD $18m upfront and will pay an additional $11m upon acceptance of the IND filing (filing expected by the end of

The injection is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. Feraheme is contraindicated in patients with evidence of iron overload,